Assignee
KASHIV BIOSCIENCES LLC
US·21 granted patents·41 pending applications·45 citations·filing 2013–2025
Top patents by PatentIndex Score
62 records- 0197US10898430B2Self-regulating osmotic gastroretentive drug delivery systemsKASHIV BIOSCIENCES LLC·Filed 2020·Granted Jan 26, 2021·5 cites·12 claims
- 0297US10898431B2Programmable pharmaceutical compositions for chrono drug releaseKASHIV BIOSCIENCES LLC·Filed 2020·Granted Jan 26, 2021·8 cites·11 claims
- 0397US10869839B2Extended release compositions comprising trihexyphenidylKASHIV BIOSCIENCES LLC·Filed 2020·Granted Dec 22, 2020·5 cites·11 claims
- 0497US10849846B2Self-regulating osmotic gastroretentive drug delivery systemsKASHIV BIOSCIENCES LLC·Filed 2020·Granted Dec 1, 2020·6 cites·20 claims
- 0595US10744083B2Self-regulating osmotic gastroretentive drug delivery systemsKASHIV BIOSCIENCES LLC·Filed 2019·Granted Aug 18, 2020·6 cites·13 claims
- 0692US12139510B2Process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2024·Granted Nov 12, 2024·3 cites·21 claims
- 0791US10744093B2Extended release compositions comprising pyridostigmineKASHIV BIOSCIENCES LLC·Filed 2020·Granted Aug 18, 2020·2 cites·18 claims
- 0891US10588863B2Extended release compositions comprising pyridostigmineKASHIV BIOSCIENCES LLC·Filed 2019·Granted Mar 17, 2020·2 cites·19 claims
- 0986US12378282B2Process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2024·Granted Aug 5, 2025·0 cites·8 claims
- 1086US11229606B2Extended release compositions comprising pyridostigmineKASHIV BIOSCIENCES LLC·Filed 2019·Granted Jan 25, 2022·1 cites·18 claims
- 1186US10987311B2Extended release compositions comprising pyridostigmineKASHIV BIOSCIENCES LLC·Filed 2019·Granted Apr 27, 2021·2 cites·20 claims
- 1285US10857098B2Gastroretentive dosage forms for sustained drug deliveryKASHIV BIOSCIENCES LLC·Filed 2020·Granted Dec 8, 2020·1 cites·14 claims
- 1385US10406234B2Method of manufacturing fine particles suitable for orally disintegrating pharmaceutical dosage formsKASHIV BIOSCIENCES LLC·Filed 2015·Granted Sep 10, 2019·2 cites·17 claims
- 1483US12435106B2Process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2024·Granted Oct 7, 2025·0 cites·29 claims
- 1583US2025353877A1Process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2025·Application pending·0 cites
- 1679US10500282B2Supersaturated stabilized nanoparticles for poorly soluble drugsKASHIV BIOSCIENCES LLC·Filed 2013·Granted Dec 10, 2019·2 cites·9 claims
- 1776US2024287159A1Process for preparation of stable protein solutionKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 1873US12440534B2Stable ready to dilute composition of carfilzomibKASHIV BIOSCIENCES LLC·Filed 2024·Granted Oct 14, 2025·0 cites·16 claims
- 1972US2025099873A1Process of affinity chromatographyKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 2070US2025043027A1Formulation of highly concentrated pharmacologically active antibodyKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 2170US2024317799A1Process for purification of proteinKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 2270US2023340080A1Process for preparation of stable protein solutionKASHIV BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 2370US2024343758A1Process for purification of proteinKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 2469US2023167153A1An improved process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2021·Application pending·0 cites
- 2568US2026014226A1Stable ready to dilute composition of carfilzomibKASHIV BIOSCIENCES LLC·Filed 2025·Application pending·0 cites
- 2667US2024352061A1Process for separation and quantification of non-ionic surfactantKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 2765US2025296014A1An improved process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2025·Application pending·0 cites
- 2864US2025059230A1An improved method for separation of low molecular weight proteinsKASHIV BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 2964US2019343957A1Method Of Manufacturing Fine Particles Suitable For Orally Disintegrating Pharmaceutical Dosage FormsKASHIV BIOSCIENCES LLC·Filed 2019·Application pending·0 cites
- 3063US2025244334A1An improved method for separating and detecting of free or residual polyethylene glycol in pegylated protein mixtureKASHIV BIOSCIENCES LLC·Filed 2023·Application pending·0 cites
- 3160US2024343776A1Process for purification of fusion proteinKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 3260US2022267473A1Formulation of highly concentrated pharmacologically active antibodyKASHIV BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 3358US2023166201A1An improved process of affinity chromatographyKASHIV BIOSCIENCES LLC·Filed 2021·Application pending·0 cites
- 3458US2023166200A1An improved process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2021·Application pending·0 cites
- 3558US2024254160A1Separation of pre-peak and post-peak in fusion protein sample by using size exclusion high performance liquid chromatographyKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 3657US2024400612A1An improved process for purification of fusion proteinKASHIV BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 3756US10744131B2Abuse-resistant drug formulationsKASHIV BIOSCIENCES LLC·Filed 2014·Granted Aug 18, 2020·0 cites·20 claims
- 3855US12352759B2Assay method of antibodyKASHIV BIOSCIENCES LLC·Filed 2024·Granted Jul 8, 2025·0 cites·19 claims
- 3954US2024156907A1Novel formulation of fusion proteinKASHIV BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 4053US2025296015A1An improved process of purification of proteinKASHIV BIOSCIENCES LLC·Filed 2025·Application pending·0 cites
- 4152US2025236640A1Separation of pre-peak in fusion protein sample by using size exclusion high performance liquid chromatographyKASHIV BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 4252US2022241184A1Gastroretentive dosage forms of levodopa and carbidopaKASHIV BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 4352US2024287207A1Process for improving polypeptide expression in mammalian cell cultureKASHIV BIOSCIENCES LLC·Filed 2024·Application pending·0 cites
- 4452US2022260521A1A process for separation and quantitation of proteins using capillary electrophoresisKASHIV BIOSCIENCES LLC·Filed 2020·Application pending·0 cites
- 4551US2023348530A1An improved process of storing and preparing the proteinKASHIV BIOSCIENCES LLC·Filed 2021·Application pending·0 cites
- 4648US2023158099A1Stable ready to dilute formulations of carfilzomibKASHIV BIOSCIENCES LLC·Filed 2021·Application pending·0 cites
- 4747US2021145846A1High-concentration fulvestrant compositionsKASHIV BIOSCIENCES LLC·Filed 2018·Application pending·0 cites
- 4846US2025136931A1An improved cell culture process for production of proteinKASHIV BIOSCIENCES LLC·Filed 2023·Application pending·0 cites
- 4945US2024069025A1Method for size based evaluation of pancreatic protein mixtureKASHIV BIOSCIENCES LLC·Filed 2022·Application pending·0 cites
- 5045US2023303621A1Improved process for the separation and analysis of pancreatic enzymesKASHIV BIOSCIENCES LLC·Filed 2023·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when KASHIV BIOSCIENCES LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →